List of Top Biotech Breakout Candidates
Small-Cap Biotechs That Could Run at Anytime
LAS VEGAS, NV / ACCESSWIRE / March 21, 2016 / It has been an exciting few weeks for biotechnology stocks, and this week should be no different. Breakouts in the biotech sector are nothing new, and here's a few stocks you should take an immediate look at:
Propanc Health Group (PPCH) with it's epic breakout last year around this same time of the year, this stock has massive breakout potential written all over it. This time last year the company was far less progressed, than it is now but it was trading at about 6X the current valuation. Remember this, multi-baggers from time to time have long periods of stagnation, or even pullback as fundamentals backfill. As we see it fundamentals have filled in quite significantly, the company has posted huge efficacy and findings from multiple research studies. And now the company has their eye on clinical trials. The company has been having an amazing year, and recently released an 8K regarding an update on its $4 million dollar financing agreement that is continuing to fund the company's operations as they approach the all important human trials. The conditions of the financing are quite favorable relative to most companies in their position, and therefore should be seen as an extremely positive sign for investors.
To date with the money they've drawn from said financing they have made amazing progress since initiating last year. They have successfully progressed through animal studies, and identified several patents for their PRP treatment. The company has stated that this financing will help prepare their lead product for human trials. So it can be inferred from this 8K that the human trials are imminent and this could be a game changer for investors. Make sure to take a very close look at PPCH.
Vitae Pharmaceuticals, Inc. (VTAE) This company's stock closed up over 5% on Friday, and has a rather reasonable valuation. With 52W HIGH of over $18, this company should be on your short list.
Zynerba Pharmaceuticals, Inc. (ZYNE) This stock closed up nearly 8% on Friday, and is trading at about 25% of it's 52W HIGH. Looking into this company is a total no brainer!
Additional Companies to watch include:
Vericel Corporations (VCEL), Syndax Pharmaceuticals, Inc. (SNDX), & Proteostasis Therapeutics, Inc. (PTI)
From all of these the highest profit potential maybe with PPCH, if they're major goals are achieved the increase in valuation could be absolutely massive!
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC. which owns Microcapspeculators.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC. which owns, Microcapspeculators.com may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC. which owns Microcapspeculators.com may be compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC. has been compensated $45,000 by Propanc Health Group, Corp. for this news article and for previous as well as future news articles.
Contact:
SOURCE: ACR Communication, LLC
